1. All Products
  2. CARBAMAZEPINE, 100mg/5ml, oral sol., 300ml, bot.
Public Pricelist

CARBAMAZEPINE, 100mg/5ml, oral sol., 300ml, bot.

https://medicalguidelines.msf.org/en/node/370
https://unicat.msf.org/cat/product/68659
STD DORACARB1S3

Valid Article

Former Code(s): DORAZBE0082 DORACARB3S- DORACARB1S-
Article is intended to be used with children (<12 years) ONLY.
24.2.2 - Medicines for bipolar disorders
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
5.1 - Antiseizure medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N03AF01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

CARBAMAZEPINE

Therapeutic Action

Antiepileptic, mood stabiliser

Indications

Epilepsy generalised tonic-clonic seizures and focal (partial) seizures

Neuropathic pain

Prevention of recurrence of bipolar disorder

Instructions for use

The oral solution is intended for paediatric use.

Precautions for Use

Due to the numerous and potentially severe adverse effects associated with carbamazepine, closely monitor the patient throughout the treatment.

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity